A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
NBC News on MSN7d
FDA approves new type of nonopioid painkiller for acute painThe drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Ibuprofen, a common painkiller, is found to boost memory and intelligence in a University College London study. While some ...
the most common side effects experienced by study participants after taking Journavx included muscle spasms, itching, and rashes. Suzetrigine belongs to a new class of non-opioid pain medications ...
Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results